Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — 9M 2015 Earnings Presentation

9 slides from Novonesis A/s Class B's earnings presentation, Oct 22, 2015

  1. Slide 1: Conference call 9M 2015

    Conference call 9M 2015 ​October 22, 2015

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements ​This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "be

  3. Slide 3: 9M 2015 Summary

    9M 2015 Summary ​9M sales in line with expectations Sales and organic growth 9M 2013 – 9M 2015 • 4% organic sales growth driven by Agriculture & Feed and Food & DKKm Beverages. 14% growth in DKK. 3% organic sales growth in Q3 10% 8% 11,000 • Challenging market conditions in Household Care and Bioene

  4. Slide 4: Ethanol plant economics per quarter – revenue, corn and EBITDA

    Ethanol plant economics per quarter – revenue, corn and EBITDA ​Assumptions: ​Yields: A changing environment • 100m gal/yr dry-grind ethanol plant • Ethanol: 2.8 gal/bushel for ethanol producers: • Equal production through quarters (25m gal) • DDGS: 16 lb/bushel • Avg. quarterly pricing used • Corn

  5. Slide 5: Bioenergy Sales

    Bioenergy Sales US quarterly ethanol volume growth rates and NZ organic growth U.S. ethanol volume growth Novozymes org. Bioenergy growth 40% 9M sales down 1% organically due to mix and share pressure – negative 6% in Q3 alone 30% Sales stabilized from Q2 to Q3, both in DKK and USD 20% 10% Innovatio

  6. Slide 6: Sales & Markets

    Sales & Markets ​9M 2015 sales: DKK +14%, organic +4% Sales by industry, DKKm DKK growth /org. growth ​Q3 2015 sales: DKK +11%, organic +3% Household 3,484 Household Care: Strong growth from a number of important customers Care 3,262 +7%/1% across markets offset challenging LATAM, a dynamic U.S. mar

  7. Slide 7: Business Development and R&D Update

    Business Development and R&D Update ​Hyaluronic acid activities closed ​Acquisition of probiotic capabilities Two new products launched: • Commercial outlook no longer • Arkansas, U.S.-based company Bioenergy: Novozymes Liquozyme® LpH warranted ongoing investment specialized in probiotics for poultr

  8. Slide 8: 9M 2015 Financial Performance & Outlook

    9M 2015 Financial Performance & Outlook ​Strong earnings performance after 9M 2015 Key Realized 2015 Outlook 2015 Outlook • Gross margin up due to productivity improvements financials 9M 2015 Oct. 22 Aug. 6 • Disregarding the net one-time impact from The BioAg Alliance, Sales growth, org. +4% 4-5% 4

  9. Slide 9: Novozymes – Rethink Tomorrow

    x novozymes’ Rethink Tomorrow

Novozymes — 9M 2015 Earnings Presentation on 6ix